Pub. Date : 2010 Nov
PMID : 21129605
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Another mTOR inhibitor, everolimus, has shown clinical benefit post-tyrosine kinasis inhibitors failure in a phase III study and is considered the standard of care in this setting. | Tyrosine | mechanistic target of rapamycin kinase | Homo sapiens |